About Impolin
Impolin is a Healthcare company based in Taby (Sweden) founded in 2004, and was acquired by Navamedic in May 2022. Diversified drugs are distributed by Impolin in Sweden. Its chief executive, as recorded, is Kathrine Gamborg Andreassen. Its focus areas include Pharmaceutical Distributors and Diversified. Its competitors include Kronans Apotek, Immedica and Swetrade Pharmaceuticals.
Company details
Impolin was founded in 2004 and is based in Täby, Sweden, where operations focus on the distribution of diversified pharmaceutical products. The company serves the healthcare sector by supplying a range of drugs to various markets within the region. Leadership is provided by CEO Kathrine Gamborg Andreassen, ensuring structured oversight of logistics and compliance in pharmaceutical distribution.
- Headquarters Taby, Sweden
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website impolin.se
- Social LinkedIn
- Acquired by Navamedic (May 2022)
Investors in Impolin
Impolin has secured backing from 1 investor. Prominent investors backing the company include Navamedic.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Traditional company manufacturing and marketing a range of pharmaceutical formulation products | 2004 | navamedic.com | Lysaker, Norway |
Investor details for Impolin
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Impolin
1 people are tracked at Impolin (1 in leadership).
| Name | Role | Group |
|---|---|---|
Kathrine Gamborg Andreassen | CEO | Leadership |
Complete people profiles for Impolin
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Impolin
2 dated milestones of Impolin across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Impolin is founded.
- Exit Acquired by Navamedic.
Competitors of Impolin
Impolin has 3 listed competitors in our database. They include Kronans Apotek, Immedica and Swetrade Pharmaceuticals.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| kronansapotek.se | 2009 | Stockholm, Sweden | Pharmaceutical products are distributed by Kronans Apotek in Sweden. | |||
| immedica.com | 2017 | Stockholm, Sweden | Therapeutic agents for oncology, neurology, and related diseases are developed. | |||
| swetradepharma.com | 2004 | Stockholm, Sweden | Pharmaceuticals and vaccines for human and animal use are supplied. |
Detailed competitors of Impolin
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Impolin
Complete news archive for Impolin
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Impolin
Impolin was founded in 2004.
Impolin is headquartered in Taby, Sweden.
Kathrine Gamborg Andreassen is the CEO of Impolin, as recorded in our data.
Impolin was founded in 2004 and is based in Täby, Sweden, where operations focus on the distribution of diversified pharmaceutical products. The company serves the healthcare sector by supplying a range of drugs to various markets within the region. Leadership is provided by CEO Kathrine Gamborg Andreassen, ensuring structured oversight of logistics and compliance in pharmaceutical distribution.
Impolin's top competitors include Kronans Apotek, Immedica and Swetrade Pharmaceuticals.
Impolin has 1 investor. Key investors include Navamedic.
Yes. Impolin was acquired by Navamedic in May 2022.